Juliet Tammenoms Bakker is Director at RxSight, Inc. (RXST). They have made 22 open-market trades across 11 companies since 2016, most recently 2026-06-17.
CIK 0001431159
13 open-market purchases totalling $56.3M since 2016, against 9 sales. Across 13 scored buys the stock is up 7.7% at ninety days, and 8.7 points ahead of the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 46% | 46% | 46% |
| Avg Move | +0.6% | +0.3% | +7.7% |
| Alpha | +1.4% | +0.9% | +8.7% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CBLL | BUY | 2024-10-15 | 2024-10-16 | $17.00 | $4.0M | -3.3% | -1.2% | -28.9% |
| RXST | BUY | 2024-05-17 | 2024-05-21 | $61.09 | $305K | -10.1% | -11.0% | -16.0% |
| RXST | BUY | 2024-02-12 | 2024-02-15 | $50.84 | $407K | +2.5% | -15.0% | +16.9% |
| RXST | SELL | 2023-11-28 | 2023-11-30 | $29.73 | $29.4M | +24.6% | +21.7% | +87.3% |
| RXST | SELL | 2023-11-14 | 2023-11-16 | $27.19 | $13.6M | +4.8% | +37.3% | +83.3% |
| RXST | SELL | 2023-09-07 | 2023-09-11 | $30.14 | $2.0M | -8.4% | -15.5% | +17.1% |
| RXST | SELL | 2023-08-25 | 2023-08-28 | $29.25 | $474K | +2.8% | -2.2% | +6.9% |
| RXST | SELL | 2023-08-17 | 2023-08-18 | $29.62 | $2.0M | -3.0% | -5.8% | -6.1% |
| RXST | BUY | 2023-02-10 | 2023-02-13 | $12.50 | $6.0M | -0.8% | +8.6% | +64.5% |
| VERA | BUY | 2022-02-10 | 2022-04-05 | $15.00 | $5.0M | +0.5% | -19.6% | -39.7% |
| SRRA | BUY | 2022-02-02 | 2022-02-02 | $27.00 | $4.7M | +2.7% | +1.5% | +81.5% |
| RXST | BUY | 2021-08-03 | 2021-08-05 | $16.00 | $10.2M | -14.4% | +14.4% | -6.6% |
| EAR | BUY | 2020-10-20 | 2020-10-22 | $18.00 | $4.2M | -3.5% | +1.4% | +54.8% |
| AXNX | SELL | 2020-09-18 | 2020-09-22 | $42.67 | $782K | +11.1% | +10.7% | +8.8% |
| AXNX | SELL | 2020-08-14 | 2020-08-18 | $43.22 | $207K | -0.9% | -2.8% | +7.2% |
| INZY | BUY | 2020-07-28 | 2020-07-28 | $16.00 | $10.0M | +21.8% | +54.8% | +28.3% |
| AXNX | BUY | 2018-11-02 | 2018-11-02 | $15.00 | $8.0M | -0.1% | -7.5% | -3.6% |
| MTEM | BUY | 2018-09-21 | 2018-09-25 | $5.50 | $2.0M | +2.8% | -21.4% | -34.9% |
| AIMT | BUY | 2018-02-22 | 2018-02-26 | $32.00 | $300K | +12.1% | +2.9% | +4.8% |
| COLL | SELL | 2017-12-08 | 2017-12-12 | $17.34 | $17.3M | +4.1% | +13.7% | +47.5% |
| CORT | SELL | 2016-11-15 | 2016-11-17 | $9.55 | $3.3M | -12.8% | -12.0% | -12.0% |
| AIMT | BUY | 2016-03-29 | 2016-03-31 | $13.88 | $1.1M | -2.2% | -4.2% | -20.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| AIMT |
| 16,651 |
| $574K |
| RXST | 85,183 | $384K |
| MTEM | 3,261,535 | $350K |
| AXNX | 3,500 | $248K |
| EAR | 3,008 | $8K |
| Total | $135.4M |
Shares reported on the most recent Form 4, priced at the 2026-06-18 close.